Rorze (6323) Q4 2025 earnings summary

Executive summary

• Achieved record revenue of ¥1,244.1 billion, up 33.4% year-over-year, driven by strong demand in semiconductor and FPD-related equipment and favorable currency effects.

• Operating income rose 32.7% to ¥32.0 billion, and net income increased 20.7% to ¥23.6 billion compared to the previous year.

• Growth was led by advanced semiconductor investments, especially in the US, Taiwan, and China, and large FPD system deliveries in Korea.

• Significant growth in the semiconductor & FPD equipment segment offset a decline in the life sciences segment.

• Major acquisition: Nanoverse Technologies, Ltd. became a consolidated subsidiary, contributing to goodwill and future growth.

Financial highlights

• Revenue: ¥1,244.1 billion (+33.4% YoY); Operating income: ¥32.0 billion (+32.7% YoY); Net income: ¥23.6 billion (+20.7% YoY).

• Gross profit margin improved as gross profit rose from ¥35,257 million to ¥49,618 million year-over-year.

• Cash and deposits at high levels, enabling large-scale investments with internal funds; cash and equivalents at year-end increased to ¥61,330 million.

• Total assets grew to ¥187,738 million, with equity ratio rising to 62.8%.

• Dividend per share increased to ¥17 (post-split basis), with payout ratio at 12.7%.

Outlook and guidance

• FY2026 revenue forecast at ¥1,281.9 billion (+3.0% YoY); operating income expected to decrease to ¥30.3 billion (-5.2% YoY).

• Net income guidance is ¥23,499 million, nearly flat year-over-year.

• Semiconductor equipment sales projected to grow 4.4% YoY; FPD equipment sales expected to decline 23.8% YoY due to prior large deliveries.

• Life science equipment sales forecast to rise 48% YoY.

• Ongoing geopolitical risks, US-China trade restrictions, and global regulations may impact demand.